Skip to main content
SpringerLink
Log in

Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland

  • Original Research Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Background

Polypharmacy and potentially inappropriate medication (PIM) are associated with adverse outcomes such as hospitalization, loss of productivity, and death.

Objective

This study evaluates the prevalence of polypharmacy and PIM in the adult community-dwelling population in Switzerland.

Methods

The analysis is done based on claims data from the largest health insurance in Switzerland. We calculated the number of medications submitted for reimbursement, the proportion of persons with polypharmacy, and the proportion of persons receiving PIM according to the 2003 Beers criteria and the PRISCUS list. Additionally, we estimated cost for medications and PIM, and identified the most prevalent groups of PIM according to the Anatomical Therapeutic Chemical Classification System (ATC).

Results

17 % of the adult community-dwelling population in Switzerland received 5 or more medications which is one of the common definitions of polypharmacy, and over 21 % of adults aged more than 65 years had a PIM according to 2003 Beers criteria or the PRISCUS list. The most prevalent classes of PIM were psycholeptics, sex hormones, psychoanaleptics, and antiinflammatory drugs.

Conclusion

Although the present study has a number of limitations, we conclude that the prevalence of polypharmacy and PIM in Switzerland is high. A broad spectrum of interventions on the individual level as well as on the population level is urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. World Health Organization, Medicines: safety of medicines—adverse drug reactions, Fact sheet No 293 [online]. 2008. http://www.who.int/mediacentre/factsheets/fs293/en/index.html. Accessed 04 Oct 2012.

  2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255–9.

    Article  PubMed  CAS  Google Scholar 

  3. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9.

    Article  PubMed  Google Scholar 

  4. Albert SM, Colombi A, Hanlon J. Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database. Drugs Aging. 2010;27(5):407–15.

    Article  PubMed  Google Scholar 

  5. Ruggiero C, Dell‘Aquila G, Gasperini B, et al. Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging. 2010;27(9):747–58.

    Article  PubMed  Google Scholar 

  6. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22(1):69–82.

    Article  PubMed  Google Scholar 

  7. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17(4):123–32.

    Article  PubMed  Google Scholar 

  8. Goldberg RM, Mabee J, Chan L, Wong S. Drug–drug and drug–disease interactions in the emergency department: analysis of a high-risk population. Am J Emerg Med. 1996;14(5):447–50.

    Article  PubMed  CAS  Google Scholar 

  9. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med. 1997;157(14):1531–6.

    Article  PubMed  CAS  Google Scholar 

  10. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.

    Article  PubMed  Google Scholar 

  11. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.

    Article  Google Scholar 

  12. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156(3):385–91.

    PubMed  CAS  Google Scholar 

  13. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–31.

    Article  PubMed  Google Scholar 

  14. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–51.

    PubMed  Google Scholar 

  15. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol. 2010;69(5):543–52.

    Article  PubMed  Google Scholar 

  16. Haider SI, Johnell K, Thorslund M, Fastbom J. Trends in polypharmacy and potential drug–drug interactions across educational groups in elderly patients in Sweden for the period 1992–2002. Int J Clin Pharmacol Therap. 2007;45(12):643–53.

    CAS  Google Scholar 

  17. Egger SS, Bachmann A, Hubmann N, Schlienger RG, Krähenbühl S. Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging. 2006;23(10):823–37.

    Article  PubMed  Google Scholar 

  18. Fialová D, Topinková E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.

    Article  PubMed  Google Scholar 

  19. Hanlon JT, Schmader K, Ruby C, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc. 2001;49(2):200–9.

    Article  PubMed  CAS  Google Scholar 

  20. Federal Office of Public Health. Bundesgesetz vom 18. März 1994 über die Krankenversicherung (KVG) [online]. http://www.admin.ch/ch/d/sr/c832_10.html. Accessed 04 Oct 2012.

  21. Hertzlinger RE, Parsa-Parsi R. Consumer-driven health care: lessons from Switzerland. JAMA. 2004;292(10):1213–20.

    Article  Google Scholar 

  22. World Health Organization. ATC/ DDD Index 2012 [online]. http://www.whocc.no/atc_ddd_index/. Accessed 04 Oct 2012.

  23. Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD. Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging. 2007;24(1):37–55.

    Article  PubMed  CAS  Google Scholar 

  24. Interpharma. Pharma-Markt Schweiz 2012 [online]. http://www.interpharma.ch/de/fakten-und-statistiken/Pharma-Markt-Schweiz.asp. Accessed 04 Oct 2012.

  25. Rochon P, Gurwitz J. Prescribing for seniors: neither too much nor too little. JAMA. 1999;282(2):113–5.

    Article  PubMed  CAS  Google Scholar 

  26. Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy—an individual-based study of the Swedish population 2005–2008. BMC Clin Pharmacol. 2010;10:16.

    Article  PubMed  Google Scholar 

  27. Slabaugh SL, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging. 2010;27(12):1019–28.

    Article  PubMed  Google Scholar 

  28. Amann U, Schmedt N, Garbe E. Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS List. Dtsch Arztebl Int. 2012;109(5):69–75.

    PubMed  Google Scholar 

  29. Felder S, Meier M, Schmitt H. Health care expenditure in the last months of life. J Health Econ. 2000;19(5):679–95.

    Article  PubMed  CAS  Google Scholar 

  30. Werblow A, Felder S, Zweifel P. Population ageing and health care expenditure: a school of ‘red herrings’? Health Econ. 2007;16(10):1109–26.

    Article  PubMed  Google Scholar 

  31. Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54.

    Article  PubMed  CAS  Google Scholar 

  32. Samsa GP, Hanlon JT, Schmader KE, et al. A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol. 1994;47(8):891–6.

    Article  PubMed  CAS  Google Scholar 

  33. Organisation for Economic Co-operation and Development. OECD Reviews of Health Systems—Switzerland [online]. http://www.oecd.org/health/healthpoliciesanddata/oecdreviewsofhealthsystems-switzerland.htm. Accessed 04 Oct 2012.

Download references

Acknowledgements

The study was funded by own resources of the Helsana group and the Swiss Center for Telemedicine Medgate. The sponsors had no role in the design and conduct of the study nor in the decision to submit this manuscript.

Conflicts of interest

None declared.

Author information

Authors and Affiliations

  1. Swiss Center for Telemedicine Medgate, Basel, Switzerland

    Eva Blozik & Jan von Overbeck

  2. Department of Primary Medical Care, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Eva Blozik

  3. Department of Health Sciences, Helsana Group, Zurich, Switzerland

    Roland Rapold & Oliver Reich

Authors
  1. Eva Blozik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roland Rapold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan von Overbeck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Blozik.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 119 kb)

Supplementary material 2 (DOCX 118 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blozik, E., Rapold, R., von Overbeck, J. et al. Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland. Drugs Aging 30, 561–568 (2013). https://doi.org/10.1007/s40266-013-0073-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-013-0073-0

Keywords

Search

Navigation